My lede:
GlaxoSmithKline plc, the world’s No. 2 selling drugmaker, said in September it will stop taking continuing medical education grant applications from medical education and…
My lede:
Two New England physicians are taking on a state law they argue interferes with their ability to prescribe life-ending doses of medication to terminally ill patients who request it.
RT @jacobgrier: Oh man, I can’t believe the play that sports team just made in that sports game! #sports
“When the truth is found to be lies, and all the joy within you dies … then what?” (http://bit.ly/Ughqp)
My lede:
White physicians, like white lawyers and white people with doctoral degrees, are not immune from an implicit preference for white people over black people, according to a study in…
My lede:
A $2.3 billion settlement with Pfizer Inc. over off-label drug promotion has industry observers wondering whether the record-breaking deal will deter drugmakers from talking up…
My lede:
Research participants want to be told about clinical investigators’ financial conflicts, and sharing that information usually enhances trust, a new study says.
But researchers…
RT @mleewelch: Worst sports column in history? (Via Baseball Primer): http://bit.ly/b0JJl
If you’ve ever wondered, “Can I peg a sports column to a woman’s 18-year ordeal as a sexual prisoner?” — here you go: http://is.gd/35nCC
This is a big feature story, so here is my longish lede:
Deciding whether to participate in a clinical trial is not easy, no matter where the study takes place. Patients are faced with a…
My lede:
A 2006 Archives of Internal Medicine study of 725 million prescriptions found that about one in five orders was written off-label — that is, for a condition that has not received the…
I am a riddle, wrapped in a mystery, inside an enigma, baked in layers of phyllo dough until I become flaky and golden brown.
